O-GlcNAcylation Is Involved in the Regulation of Stem Cell Markers Expression in Colon Cancer Cells
Open Access
- 8 May 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 10, 289
Abstract
The dynamic O-linked-N-acetylglucosamine posttranslational modification of nucleocytoplasmic proteins has emerged as a key regulator of diverse cellular processes including several hallmarks of cancer. However, the role played by this modification in the establishment of CSC phenotype has been poorly studied so far and remains unclear. In this study we confirmed the previous reports showing that colon cancer cells exhibit higher O-GlcNAc basal levels than non-malignant cells, and investigated the role played by O-GlcNAcylation in the regulation of CSC phenotype. We found that the modification of O-GlcNAcylation levels by pharmacological inhibition of the O-GlcNAc-transferase enzyme that adds O-GlcNAc (OGT), but not of the enzyme that removes it (OGA), increased the expression of all stem cell markers tested in our colon malignant cell lines, and induced the appearance of a double positive (CD44+/CD133+) small stem cell-like subpopulation (which corresponded to 1–10%) that displayed very aggressive malignant phenotype such as increased clonogenicity and spheroid formation abilities in 3D culture. We reasoned that OGT inhibition would mimic in the tumor the presence of severe nutritional stress, and indeed, we demonstrated that nutritional stress reproduced in colon cancer cells the effects obtained with OGT inhibition. Thus, our data strongly suggests that stemness is regulated by HBP/O-GlcNAcylation nutrient sensing pathway, and that O-GlcNAc nutrient sensor represents an important survival mechanism in cancer cells under nutritional stressful conditions.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
This publication has 35 references indexed in Scilit:
- CD133: a stem cell biomarker and beyondExperimental Hematology & Oncology, 2013
- O-GlcNAcylation: A New Cancer Hallmark?Frontiers in Endocrinology, 2013
- Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progressionMolecular Cancer, 2012
- The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancersCell Research, 2011
- Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasisSurgical Oncology, 2011
- Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cellsClinical & Experimental Metastasis, 2011
- O-GlcNAcylation is a novel regulator of lung and colon cancer malignancyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Overexpression of CD133 Promotes Drug Resistance in C6 Glioma CellsMolecular Cancer Research, 2010
- An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and DiseaseCell Stem Cell, 2010
- On the Origin of Cancer CellsScience, 1956